) in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.
Mylan shareholders would receive a little more than 40% of the newly formed entity, with Pfizer shareholders receiving the remainder, the Journal said, adding Pfizer would also get about $12 billion in proceeds from a new sale of debt.Reporting by Maria Ponnezhath in Bengaluru; Editing by Mark Potter
Source: News Formal (newsformal.com)
Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Source: WSJ - 🏆 98. / 63 Read more »
FDA Requires Box Warnings for Pfizer Drug XeljanzThe U.S. Food and Drug Administration is requiring that health warnings be added to Pfizer Inc.’s drug Xeljanz, advising patients they could experience a higher risk of blood clots or death with a specific dose. As the warnings clearly state Saudi_FDA buh-bye junkies...
Source: WSJ - 🏆 98. / 63 Read more »
Pfizer Nears Deal to Combine off-Patent Drug Business With MylanPfizer is in talks to merge its off-patent drugs business with generic drugmaker Mylan, in a deal that would create a giant global seller of lower-priced medicines. Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención jonathanrockoff so that they can raise the price? Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.
Source: WSJ - 🏆 98. / 63 Read more »
FDA Requires Box Warnings for Pfizer Drug XeljanzThe U.S. Food and Drug Administration is requiring that health warnings be added to Pfizer Inc.’s drug Xeljanz, advising patients they could experience a higher risk of blood clots or death with a specific dose. As the warnings clearly state Saudi_FDA buh-bye junkies...
Source: WSJ - 🏆 98. / 63 Read more »
The Tiny Drug Dealer Kid From 'Euphoria' Has the Best Instagram You've Ever SeenNot to be dramatic, but I would die for Ashtray.
Source: Cosmopolitan - 🏆 725. / 51 Read more »
There's no business like the arms business: Here's how the top US defense companies did in Q2 earningsNobody spends money on arms like the United States, and it shows in the bottom lines of the biggest defense contractors. 'While the companies’ quarterly performances remained strong, collectively their stocks were largely unchanged. The iShares U.S. Aerospace and Defense ETF was slightly higher for this week after the companies reported. So far this year the benchmark ETF is up nearly 26 percent.'
Source: CNBC - 🏆 12. / 72 Read more »